Abivax (ABVX) Non-cash Items (2024 - 2025)
Abivax's Non-cash Items came in at -$45.04 million for Q2 2025, compared with -$36.03 million a year earlier.
Abivax (ABVX) Non-cash Items (2024 - 2025) Analysis & Trends
Over the trailing twelve months to Jun 30, 2025, Abivax reported Non-cash Items of -$167.57 million; for FY2024, it came in at -$168.3 billion.
- Going back by year, Non-cash Items was -$128.07 billion in FY2023, -$54.74 billion in FY2022 and -$52.52 billion in FY2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Abivax | 7.61 Bn | 7.61 Bn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -45.04 Mn |
| Mar 31, 2025 | -44.48 Mn |
| Jun 30, 2024 | -36.03 Mn |
| Mar 31, 2024 | -42.02 Mn |
Abivax Non-cash Items API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-cash-items&ticker=ABVX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-cash-items", "ticker": "ABVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-cash-items&ticker=ABVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();